BioNTech SE is 2.8x more valuable than QIAGEN N.V. by market capitalization ($22.90 B vs $8.04 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | QGEN | BNTX |
|---|---|---|
| Market cap | $8.04 B | $22.90 B |
| US-listed rank | #1085 | #572 |
| Revenue (latest FY) | $2.09B | - |
| Net income (latest FY) | $424.88M | - |
| Net margin | 20.3% | - |
| P/E (trailing FY) | 18.9 | - |
| SEC filings | 471 | 548 |
BioNTech SE is 2.8x more valuable than QIAGEN N.V. by market capitalization ($22.90 B vs $8.04 B).
Full pages: QIAGEN N.V. and BioNTech SE, or browse the full rankings.